Filtered By:
Drug: Medroxyprogesterone
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 487 results found since Jan 2013.
Evaluations of memory, anxiety, and the growth factor IGF-1R after post-surgical menopause treatment with a highly selective progestin
Behav Brain Res. 2023 Apr 19:114442. doi: 10.1016/j.bbr.2023.114442. Online ahead of print.ABSTRACTProgestogens are a key component of menopausal hormone therapies. While some progestogens can be detrimental to cognition, there is preclinical evidence that progestogens with a strong progesterone-receptor affinity benefit some molecular mechanisms believed to underlie cognitive function. Thus, a progestin that maximizes progesterone-receptor affinity and minimizes affinities to other receptors may be cognitively beneficial. We evaluated segesterone-acetate (SGA), a 19-norprogesterone derivative with a strong progesterone-re...
Source: Behavioural Brain Research - April 19, 2023 Category: Neurology Authors: Victoria E Bernaud Stephanie V Koebele Steven N Northup-Smith Mari N Willeman Charlotte Barker Alex Schatzki-Lumpkin Maria Valenzuela Sanchez Heather A Bimonte-Nelson Source Type: research
Is self-administered DMPA an answer to contraception access in the post-Roe era?
J Fam Pract. 2023 Mar;72(2):84-86. doi: 10.12788/jfp.0558.ABSTRACTCompared with provider-administered depot medroxyprogesterone acetate, a prefilled formulation may offer patients improved access to effective contraception.PMID:36947783 | PMC:PMC10032666 | DOI:10.12788/jfp.0558
Source: The Journal of Family Practice - March 22, 2023 Category: Practice Management Authors: Lindsay Nakaishi Gregory Castelli Source Type: research
